Using the Emergency Department to improve lung cancer screening
Official title: LEAD Pilot Study: Leveraging the Emergency Department to Address SDOH and Reduce Lung Cancer Screening Disparities
Run by Hackensack Meridian Health · NCT06605534 · Data updated 2026-11-12
This study is testing a new way to get more people with lung cancer risk to participate in screening by using a tool in the Emergency Department that looks at their personal health needs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Hackensack Meridian Health Academic / other |
| Locations | 10 sites (Brick, New Jersey and 9 other locations) |
| Status | Recruiting |
| Started | October 29, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT06605534 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 50 to 80 who currently smoke or have quit within the last 15 years and have never undergone lung cancer screening.
✕Probably not a fit
Patients diagnosed with lung cancer or those who have previously had a lung cancer screening will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to enhance lung cancer screening uptake by utilizing an Electronic Health Record-embedded Social Determinants of Health screening tool in the Emergency Department. It will first assess the reach of this approach in identifying eligible patients for lung screening. Following this, a pilot trial will evaluate the effectiveness of a tailored intervention compared to standard care, focusing on factors that influence lung screening uptake such as health literacy and stigma. The study employs quantitative methods, including a Randomized Controlled Trial design and analysis of EHR data.
Why it matters
Potential benefit: If successful, this study could significantly increase lung cancer screening rates among high-risk populations.
How similar studies have gone: Other studies have shown promise in using non-traditional settings for health interventions, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 50 years to 80 years * Currently smoke cigarettes or quit smoking cigarettes within the past 15 years * 20 pack-year smoking history * Has never had lung cancer screening * Able to provide informed consent * Able to speak and understand English Exclusion Criteria: * Diagnosed with lung cancer * Has a history of having a lung cancer screening scan * Unable to speak and understand English
Where it's running
-
Ocean Medical Center
Brick, New Jersey, United States Recruiting -
John F. Kennedy Medical Center
Edison, New Jersey, United States Recruiting -
Hackensack University Medical Center
Hackensack, New Jersey, United States Recruiting -
Bayshore Medical Center
Holmdel, New Jersey, United States Recruiting -
Southern Ocean Medical Center
Manahawkin, New Jersey, United States Recruiting -
Jersey Shore University Medical Center
Neptune City, New Jersey, United States Recruiting
Show 4 more locations
-
Palisades Medical Center
North Bergen, New Jersey, United States Recruiting -
Old Bridge Medical Center
Old Bridge, New Jersey, United States Recruiting -
Raritan Bay Medical Center
Perth Amboy, New Jersey, United States Recruiting -
Riverview Medical Center
Red Bank, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Lisa Carter-Bawa, PhD — Hackensack Meridian Health
- Study coordinator: Ana Guadalupe Vielma, PhD
- Email: ana.vielma@hmh-cdi.org
- Phone: 2018803400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.